Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Inflamed fat: what starts the fire?
Jaap G. Neels, Jerrold M. Olefsky
Jaap G. Neels, Jerrold M. Olefsky
View: Text | PDF
Commentary

Inflamed fat: what starts the fire?

  • Text
  • PDF
Abstract

Obesity is associated with increased macrophage infiltration of adipose tissue, and these macrophages may be an important component of the chronic inflammatory response playing a crucial role in the development of insulin resistance. This prompts the question as to how macrophages infiltrate obese adipose tissue. In this issue of the JCI, Weisberg et al. show the importance of C-C motif chemokine receptor 2 (CCR2) in macrophage recruitment to adipose tissue and the development of obesity and its complications.

Authors

Jaap G. Neels, Jerrold M. Olefsky

×

Figure 1

Macrophage itinerary in adipose tissue infiltration.

Options: View larger image (or click on image) Download as PowerPoint
Macrophage itinerary in adipose tissue infiltration.
(A) Macrophage infi...
(A) Macrophage infiltration occurs after initial rolling and attachment of monocytes to activated endothelial cells. These monocytes then extravasate through the endothelial cell layer and differentiate into macrophages. In this issue of the JCI, Weisberg et al. show that CCL2 and its receptor CCR2 play an important role in macrophage chemotaxis (11). Cross-talk among adipocytes, macrophages, and endothelial cells may aggravate the inflammatory state, resulting in increased secretion of proinflammatory cytokines/chemokines, adipokines, and angiogenic factors. These factors could cause local and/or systemic insulin resistance in a paracrine and/or endocrine fashion, respectively, and might also induce local angiogenesis. (B) Adipose tissue (AT) expansion during weight gain leads to recruitment of macrophages through a variety of signals, which may include local hypoxia. These macrophages predominantly localize around dead adipocytes.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts